These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6710049)

  • 1. Aspect of the evolution of viral hepatitis two years after the acute phase.
    Miron C; Chiriloiu C; Mustea A; Tănăsescu C; Balgiu N; Sulea M
    Med Interne; 1984; 22(1):55-60. PubMed ID: 6710049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of postacute viral hepatitis: the role of HBsAg.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1986; 24(1):19-22. PubMed ID: 3704499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electron microscopic study of the sera of hepatitis B surface antigen (HBs Ag) subjects (author's transl)].
    Monges B; Remacle JP; Monges G; Payan H
    Pathol Biol (Paris); 1981 Mar; 29(3):143-9. PubMed ID: 7017557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T
    Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A histologic comparison of hepatitis B with non-A, non-B chronic active hepatitis.
    Thorne CH; Higgins GR; Ulich TR; Gitnick GL; Lewin KJ
    Arch Pathol Lab Med; 1982 Sep; 106(9):433-6. PubMed ID: 6810841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The frequency of the e-antigen in acute and chronic hepatitis (author's transl)].
    Fay OH; Tanno H; Roncoroni M; Findor J; Igartua EB; Domecq R
    Leber Magen Darm; 1975 Aug; 5(4):140-2. PubMed ID: 1223562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
    Lu P; Wang J; Wu Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
    Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
    Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.
    Chung HT; Lai CL; Lok AS
    Hepatology; 1995 Jul; 22(1):25-9. PubMed ID: 7601418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
    Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
    Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of fulminant hepatic failure in previously unrecognized HBsAg carriers with acute hepatitis independent of etiology.
    Chu CM; Liaw YF
    Infection; 2005 Jun; 33(3):136-9. PubMed ID: 15940414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.